To include your compound in the COVID-19 Resource Center, submit it here.

Inhaled alpha-1 antitrypsin regulatory update

EMA accepted for review an MAA from Kamada for inhaled alpha-1 antitrypsin (AAT) to treat

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE